Roberto Furlan

21 January 2022
120 Views

Head of Clinical Neuroimmunology Unit
Institute of Experimental Neurology
INSpe Division of Neuroscience
San Raffaele Hospital
Milan | Italy

Roberto Furlan graduated in medicine at the University of Milano in 1991.
After the MD degree, in 1992 he was visiting scientist in the Department of Neurology from the University of Chicago, working on HTLV-I.
The following year (1993) he completed a research project on HTLV-I in the Clinical Laboratories of the Sao Rafael Hospital in Salvador-Bahia, in Brazil.
From 1994 to 1995 he worked as a post-doctoral fellow in the Department of Molecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, USA on HSV-1-mediated gene therapy of the central nervous system.
Using HSV-1-derived vectors he performed gene therapy studies in multiple sclerosis models and in 2001 he obtained his PhD at the Open University of London working in the Neuroimmunology Unit of the San Raffaele Scientific Institute, Milan, Italy.
Since 2001 tenure-track research assistant Senior scientist in the Neuroimmunology Unit of the San Raffaele Scientific Institute, he completed in 2007 the residency in neurology.
Since 2004, non-tenured professor at Vita e Salute San Raffaele University, Milan.
Since 2009, Group leader and then Head of Unit of the Clinical Neuroimmunology Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan.
Since 2011 Secretary treasurer of the International Society of NeuroImmunology.
Since 2013 Academic Editor for Plos One.
2017-2021 Deputy Director of the Institute of Experimental Neurology – INSpe, San Raffaele Scientific Institute, Milan.
Since 2019 President of the Italian Neuroimmunology Association – AINI
Since 2022 Director of the Institute of Experimental Neurology – INSpe, San Raffaele Scientific Institute, Milan.

He has published over 200 papers on peer reviewed international journals. Current H-index = 63, 46 in the last five years. 

SELECTED PUBLICATIONS
1. Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J. Immunol. 1999 163:2403-2409

2. Del Maschio A, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, Fruscella P, Adorini L, Martino G, Furlan R, De Simoni MG, Dejana E. Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to Juncional Adhesion Molecule (JAM). J. Ex. Med. 1999;190:1351-1356

3. Furlan R, Brambilla E, Ruffini F, Poliani PL, Bergami A, Marconi PC, Franciotta DM, Penna G, Comi G, Adorini L, Martino G. Intrathecal delivery of IFNγ protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of CNS-infiltrating lymphocytes. J. Immunol. 2001; 167:1821-1829

4. Martino G, Furlan R, Comi G, Adorini L. The ependymal route to access the central nervous system: an emerging immuno-gene therapy approach to multiple sclerosis. Trends Immunol. 2001; 22:483-490

5. Furlan R, Brambilla E, Sanvito F, Roccatagliata L, Olivieri S, Bergami A, Pluchino S, Uccelli A, Comi G, Martino G. Vaccination with amyloid-bea peptide induces autoimmune encephalomyelitis in C57BL/6 mice. Brain. 2003;126:285-291

6. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Bergami A, Furlan R, Delcarro U, Amadio S, Comi G, Vescovi Al, Martino G. Intravenous and intracerebroventricular injection of adult neurospheres induces clinical recovery in a chronic model of multiple sclerosis. Nature 2003; 422:688-694

7. Furlan R. Bargami A, Cantarella D, Brambilla E, Taniguchi M, Dellabona P, Casorati G, Martino G. Activation of invariant NKT cells by α-GalCer administration protects mice from MOG35-55-induced EAE: a critical role for administration rout and IFNγ. Eur J Immunol. 2003; 33:1830-1838

8. Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G, Martinello M, Cattalini A, Bergami A, Furlan R, Comi G, Constantin G, Martino G. Neurosphere-derived multipotent precursors promote long-lasting neuroprotection by an immunomodulatory mechanism. Nature 2005 436:266-271

9. Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M. Secondary progressive MS: current knowledge an future challenges. Lancet Neurol. 2006 5:343-354

10. Butti E, Bergami A, Recchia A, Brambilla E, Franciotta D, Cattalini A, Stornaiuolo A, Comi G, Mavilio F, Martino G, Furlan R. Absence of an intrathecal immune reaction to a HD adenoviral vector delivered into the cerebrospinal fluid of non-human primates. Gene Ther. 2008 15:233-238

11. Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, Musella A, D’amelio M, Cavallucci V, Martorana A, Bergamaschi A, Cencioni Mt, Butti E, Comi G, Bernardi G, Cecconi F, Battistini L, Furlan R, Martino G. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci. 2009 29:3442-52.

12. Esposito M, Ruffini F, Bergami A, Garzetti L, Borsellino G, Battistini L, Martino G, Furlan R. IL-17 and IFN-γ secreting FoxP3+ T cells infiltrate the target tissue in experimental autoimunity. J Immunol. 2010 185:7467-73

13. Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, Riganti L, Corradini I, Francolini M, Garzetti L, Maiorino C, Servida F, Vercelli A, Dalla Libera D, Martinelli V, Comi G, Martino G, Matteoli M, Furlan R. Myeolid microvesicles are a marker and therapeutic target for neuroinflammation. Ann. Neurol. 2012 72:610-624

14. Maiorino C, Khorooshi RMH, Ruffini F, Løbner M, Bergami A, Garzetti L, Martino G, Owens T, Furlan R. IL-25 protects from neuroinflammation by modulating microglia. Gene Ther. 2013 20:487-496

15. Agosta F, Dalla Libera D, Gioele Spinelli E, Finardi A, Canu E, Bergami A, Bocchio Chiavetto L, Baronio M, Comi G, Martino G, Matteoli M, Magnani G, Verderio C, Furlan R. Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. Ann. Neurol. 2014 doi: 10.1002/ana.24235

16. Casella G, Finardi A, Descamps H, Colombo F, Maiorino C, Ruffini F, Patrone M, Degano M, Martino G, Muzio L, Becher B, Furlan R. BIL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression. Scientific Reports. 2017 7:16547. doi: 10.1038/s41598-017-16702-w

17. Colombo F. Bastoni M. Nigro A, Podini P, Finardi A, Casella G, Ramesh M, Farina C, Verderio C, Furlan R. Cytokines stimulate the release of microvesicles from myeloid cells independently from the P2X7-receptor/acid sphingomyelinase pathway. Front. Immunol. In press.

18. Casella G, Finardi A, Descamps H, Colombo F, Maiorino C, Ruffini F, Patrone M, Degano M, Martino G, Muzio L, Becher B, Furlan R. IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression. Scientific Reports. 2017 7:16547. doi: 10.1038/s41598-017-16702-w

19. Colombo F, Bastoni M, Nigro A, Podini P, Finardi A, Casella G, Ramesh M, Farina C, Verderio C, Furlan R. Cytokines stimulate the release of microvesicles from myeloid cells independently from the P2X7-receptor/acid sphingomyelinase pathway. Front. Immunol. 2018 doi: 0.3389/fimmu.2018.00204

20. Casella G, Colombo F, Finardi A, Ill-Ragaa G, Spinelli A, Podini P, Bastoni M, Descamps H, Muzio L, Furlan R. Phagocytes-targeted extracellular vesicles containing IL4 inhibit neuroinflammation in a mouse model of multiple sclerosis. Mol. Ther. 2018 26:2107-2118. doi: 10.1016/j.ymthe.2018.06.024.

21. Furlan R, Melloni E, Finardi A, Vai B, Di Toro S, Aggio V, Battistini L, Borsellino G, Manfredi E, Falini A, Colombo C, Poletti S, Benedetti F. Natural Killer cells protect white matter integrity in Bipolar Disorder. Brain Behav Immun. 2019 doi: 10.1016/j.bbi.2019.06.037

22. Colombo F, Casella G, Podini P, Finardi A, Racchetti G, Norton E.G., Cocucci E., Furlan R. Polarized cells display asymmetric 1 release of extracellular vesicles. Traffic 2020  doi: 10.1111/tra.12775.

23. De Lorenzo R, Loré N, Finardi A, Mandelli A, Cirillo DM, Tresoldi C, Benedetti F, Ciceri F, Rovere-Querini P, Comi G, Filippi M, Manfredi AA, Furlan R. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients. J Neurol. 2021 doi: 10.1007/s00415-021-10595-6.

24. Gelibter S Pisa M,  Croese T, Finardi A, Mandelli A, Sangalli F, Colombo B, Martinelli V, Comi G, Filippi M, Furlan R. Spinal fluid myeloid microvesicles predict disease course in multiple sclerosis. Ann. Neurol. 2021 DOI:10.1002/ana.26154.

25. Gelibter S, Marostica G, Mandelli A, Siciliani S, Podini P, Finardi A, Furlan R. The impact of storage on extracellular vesicles: a systematic study. J Extracell Vesicles. In press

You may be interested

Science Fly Zone
News
31 views
News
31 views

Science Fly Zone

stine - 15 April 2022

The International Society of Neuroimmunology stand in solidarity with the Ukrainian population and with its scientists.We fully endorse the statements by…

17th ISNI Congress – Congratulation Japan!
News
40 views
News
40 views

17th ISNI Congress – Congratulation Japan!

stine - 14 April 2022

The 17th ISNI Congress will be held in Chiba, Japan! Head of the Local organization is Professor Takashi Yamamura. 

PhD Student in Neuroimmunology – UKE Hamburg
News
437 views
News
437 views

PhD Student in Neuroimmunology – UKE Hamburg

stine - 15 March 2022

We are the UKE – the University Medical Centre Hamburg-Eppendorf [Universit tsklinikum Hamburg-Eppendorf]. A pulsating centre of health in the heart…